CELL RESPONSE AND REGULATION PROGRAM ABSTRACT The Cell Response and Regulation (CRR) Program is a basic science program at Huntsman Cancer Institute (HCI). CRR discovery science supports the Center?s mission ?to understand cancer from its beginnings? by gaining new insight into basic mechanisms of cancer biology and providing a foundation for addressing critical clinical issues according to HCI?s strategic plan. CRR members use scientific ingenuity and the extensive Shared Resources provided by HCI to make new discoveries, and they collaborate with members of the Cancer Control and Population Sciences Program and the Experimental Therapeutics Program to translate these discoveries to the clinic and population in the areas of cancer prevention, target identification, biomarker development, prognostics, diagnostics, and treatment development. CRR research is centered on the following Specific Aims: 1) to elucidate mechanisms underlying cell proliferation, differentiation, and survival; 2) to uncover mechanisms and pathways mediating tumor metastasis; and 3) to understand tumor development and response to therapy. CRR is comprised of 37 members, representing 15 academic departments and four schools/colleges at the University of Utah. CRR members are well-funded, with $8.2M in peer-reviewed grant funding, of which $3.0M (33%) is from the NCI. The remainder of the peer-reviewed funding portfolio includes grants focused on cellular cancer mechanisms from the National Institutes of Health, the Department of Defense, Susan G. Komen Foundation, and the American Cancer Society. Ninety-three percent of full members have current, peer- reviewed, cancer-focused funding. In the current funding cycle, CRR members published 266 cancer-focused papers; 14% of these represent intra-programmatic collaborations, and 41% stem from inter-programmatic collaborations. The synergistic aims of the CRR Program create a highly productive, collaborative, and impactful research environment that is bolstered by the organizational capacity, infrastructure, and Shared Resources of the Cancer Center. CRR fosters excellence in basic science discovery in cancer biology; 28% of this Program?s papers were high-impact publications (journal impact factor >10). These discoveries directly led to six new investigator-initiated trials in the current funding period. Program Leaders facilitate meaningful, productive, interdisciplinary collaborations to achieve the goal of discovering and exploiting new mechanisms that underlie tumorigenesis and metastasis. Our success in collaborative intra- and inter-programmatic science is underscored by successful competition for nine new multi-principal investigator grants in the current funding period.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA042014-31
Application #
9935886
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
31
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Yazdimamaghani, Mostafa; Moos, Philip J; Ghandehari, Hamidreza (2018) Global gene expression analysis of macrophage response induced by nonporous and porous silica nanoparticles. Nanomedicine 14:533-545
Vahrenkamp, Jeffery M; Yang, Chieh-Hsiang; Rodriguez, Adriana C et al. (2018) Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor ? In Endometrial Cancer. Cell Rep 22:2995-3005
Gupta, Sumati; Albertson, Daniel; Gaston, David et al. (2018) Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System. Clin Genitourin Cancer 16:e373-e382
Flack, Caralyn E; Parkinson, John S (2018) A zipped-helix cap potentiates HAMP domain control of chemoreceptor signaling. Proc Natl Acad Sci U S A 115:E3519-E3528
Al-Agha, Abdulmoein Eid; Ahmed, Ihab Abdulhamed; Nuebel, Esther et al. (2018) Primary Ovarian Insufficiency and Azoospermia in Carriers of a Homozygous PSMC3IP Stop Gain Mutation. J Clin Endocrinol Metab 103:555-563
Petersen, Jenna; Koptiuch, Cathryn; Wu, Yelena P et al. (2018) Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis. Patient Educ Couns 101:2011-2017
Wu, Yelena P; Aspinwall, Lisa G; Nagelhout, Elizabeth et al. (2018) Development of an Educational Program Integrating Concepts of Genetic Risk and Preventive Strategies for Children with a Family History of Melanoma. J Cancer Educ 33:774-781
Pishas, Kathleen I; Drenberg, Christina D; Taslim, Cenny et al. (2018) Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response. Mol Cancer Ther 17:1902-1916
Blackburn, Brenna E; Ganz, Patricia A; Rowe, Kerry et al. (2018) Reproductive and gynecological complication risks among thyroid cancer survivors. J Cancer Surviv 12:702-711
Ye, Zhizhou; Ayer, Donald E (2018) Ras Suppresses TXNIP Expression by Restricting Ribosome Translocation. Mol Cell Biol :

Showing the most recent 10 out of 1193 publications